MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02593cam a2200349 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
21319817 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20200722154441.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
191204s2019 nyua b 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2019302556 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781536163964 |
| Qualifying information |
(paperback) |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| Language of cataloging |
eng |
| Description conventions |
rda |
| Transcribing agency |
DLC |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RF285.O83 |
| Item number |
O86 2019 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
617.8 COL |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Ototoxicity : |
| Remainder of title |
signs, symptoms and treatment / |
| Statement of responsibility, etc. |
Gregg Colon, editor. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
New York : |
| Name of producer, publisher, distributor, manufacturer |
Nova Medicine & Health, |
| Date of production, publication, distribution, manufacture, or copyright notice |
[2019] |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xi, 157 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
23 cm. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Media type code |
n |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Carrier type code |
nc |
| Source |
rdacarrier |
| 490 0# - SERIES STATEMENT |
|---|
| Series statement |
Otolaryngology research advances |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Table of Contents<br/><br/>Preface<br/><br/>Chapter 1. Ototoxicity: Pathophysiology, Monitoring and Prevention<br/>(Pavlos Pavlidis, PhD, ENT-Clinic, Klinikum Wolfsburg, Germany)<br/><br/>Chapter 2. Ototoxic Drugs, Diagnosis and Monitoring<br/>(Yüksel Toplu MD, and Mehmet Tan, MD, Inonu University, Medical Faculty, Department of Otorhinolaryngology, Malatya, Turkey)<br/><br/>Chapter 3. Cisplatin Associated Ototoxicity: Considerations for the Health Care Professional<br/>(Jessica Paken, Cyril D. Govender, Mershen Pillay, DEd, Birhanu T. Ayele, PhD, Vikash Sewram, PhD, Discipline of Audiology, School of Health Sciences, University of KwaZulu-Natal, South Africa, and others)<br/><br/>Chapter 4. Ototoxicity and Neurotoxicity Due to Environmental Contaminants: Auditory Impact of Cigarette Smoking and Secondhand Smoke Exposure<br/>(Ishara Ramkissoon, Department of Speech Pathology and Audiology, University of South Alabama, Mobile, AL, US, and others)<br/><br/>Chapter 5. Ototoxicity of Aminoglycoside<br/>(Ela Araz Server and Cigdem Kalaycik Ertugay, Associate Professor, Istanbul Education and Research Hospital, Department of Otorhinolaryngology/Head and Neck Surgery, Istanbul, Turkey, and others)<br/><br/>Chapter 6. Aminoglycoside Mediated Ototoxicity and Hearing Loss in Cystic Fibrosis Patients: An Unmet Medical Need<br/>(Rahul Mittal, Luca H. Debs and Kalai Mathee, Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL, US, and others)<br/><br/>Index |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Ototoxic agents. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Ear |
| General subdivision |
Effect of drugs on. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Ear |
| General subdivision |
Diseases |
| -- |
Chemotherapy. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Colon, Gregg, |
| Relator term |
editor. |
| 906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
|---|
| a |
7 |
| b |
cbc |
| c |
orignew |
| d |
2 |
| e |
ncip |
| f |
20 |
| g |
y-gencatlg |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Reference text books |
